The role of protein methyltransferases as potential novel therapeutic targets in squamous cell carcinoma of the head and neck
Over the past decade, multiple studies have uncovered the significance of protein methylation in cancer development and progression. Protein lysine (PKMTs) and arginine (PRMTs) methyltransferases comprise a group of 62 enzymes that mediate the reversible deposition of methyl groups on lysine and arginine residues, respectively, on either histone or non-histone substrates. Protein demethylases (PDMTs) comprise approximately 30 enzymes and they erase these marks. Studies conducted by the Cancer Genome Atlas (TCGA) consortium have revealed multiple genetic and expression level alterations in these enzymes in multiple cancer types, including squamous cell carcinoma of the head and neck (SCCHN) [1].
Source: Oral Oncology - Category: Cancer & Oncology Authors: Vassiliki Saloura, Theodore Vougiouklakis, Cem Sievers, Kyunghee Burkitt, Yusuke Nakamura, Gordon Hager, Carter van Waes Tags: Review Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Genetics | Head and Neck Cancer | Oral Cancer | Skin Cancer | Squamous Cell Carcinoma | Study